Bentham Science Logo

Contents

Current Cancer Drug Targets, Volume 9 - Number 5

Ribonucleotide Reductase as One Important Target of [Tris(1,10- phenanthroline)lanthanum(III)] Trithiocyanate (KP772)

, 9(5): 595 - 607

P. Heffeter, A. Popovic-Bijelic, P. Saiko, R. Dornetshuber, U. Jungwirth, N. Voevodskaya, D. Biglino, M. A. Jakupec, L. Elbling, M. Micksche, T. Szekeres, B. K. Keppler, A. Graslund and W. Berger


DOI: 10.2174/156800909789056962



P-Selectin Glycoprotein Ligand-1 as a Potential Target for Humoral Immunotherapy of Multiple Myeloma (Supplementry Material)

, 9(5): 617 - 625

C. Tripodo, A. M. Florena, P. Macor, A. Di Bernardo, R. Porcasi, C. Guarnotta, S. Ingrao, M. Zerilli, E. Secco, M. Todaro, F. Tedesco and V. Franco


DOI: 10.2174/156800909789056971





Targeting of Hsp32 in Solid Tumors and Leukemias: A Novel Approach to Optimize Anticancer Therapy (Supplementry Material)

, 9(5): 675 - 689

K. V. Gleixner, M. Mayerhofer, A. Vales, A. Gruze, G. Hormann, S. Cerny-Reiterer, E. Lackner, E. Hadzijusufovic, H. Herrmann, A. K. Iyer, M.-T. Krauth, W. F. Pickl, B. Marian, R. Panzer-Grumayer, C. Sillaber, H. Maeda, C. Zielinski and P. Valent


DOI: 10.2174/156800909789057024


Emerging Strategies to Strengthen the Anti-Tumour Activity of Type I Interferons: Overcoming Survival Pathways

, 9(5): 690 - 704

M. Caraglia, M. Marra, P. Tagliaferri, S. W.J. Lamberts, S. Zappavigna, G. Misso, F. Cavagnini, G. Facchini, A. Abbruzzese, L. J. Hofland and G. Vitale


DOI: 10.2174/156800909789056980



Webmaster Contact: info@benthamscience.net
Copyright © 2018 Bentham Science